Cleveland Clinic Quantum Innovation Catalyzer Program Awardees Announced
AI-summarised brief · reviewed before publication
The Cleveland Clinic has selected three startups, EntangleBio, Polaris Quantum Biotech, and Singularity Quantum, for its 2026 Quantum Innovation Catalyzer Program. The 12-month program provides funding, expert collaboration, and access to IBM Quantum System One to advance quantum applications in healthcare and life sciences. The initiative supports research in rare disease diagnosis, drug toxicity prediction, and cardiovascular simulation, and builds on a broader Cleveland Clinic-IBM ecosystem.